Summary
- Mayer Brown has advised Vivo Capital on financing the acquisition of Dutscher Group, a top European distributor for R&D laboratory consumables and equipment.
- This transaction is set to close in the first half of 2026, pending regulatory approvals.
- The deal marks Vivo Capital's inaugural buyout investment in Europe, highlighting its expansion as a global healthcare investor.
- This move builds on Vivo Capital's established leadership in North America and Asia, signaling significant growth potential.
Join the discussion ā sign up to comment, upvote, and save articles.